Pilot Study of an Integrative New Tool for Studying Clinical Outcome Discrimination in Acute Leukemia-Reference-Cited by-同舟云学术

Pilot Study of an Integrative New Tool for Studying Clinical Outcome Discrimination in Acute Leukemia

Published:2019-04-09 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Gacha-Garay María José,Niño-Joya Andrés Felipe,Bolaños Natalia I.,Abenoza Lina,Quintero Guillermo,Ibarra Humberto,Gonzalez John M.,Akle Verónica,Garavito-Aguilar Zayra V.

Funder

Facultad de Ciencias, Universidad de los Andes

Universidad de los Andes

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference80 articles.

1. Epidemiology, pathogenesis, and etiology of acute leukemia;Fiegl,2016

2. Understanding of leukemic stem cells and their clinical implications;Wang;Mol Cancer.,2017

3. The zebrafish as a tool in leukemia research;Teittinen;Leuk Res.,2012

4. High expression of ID family and IGJ genes signature as predictor of low induction treatment response and worst survival in adult Hispanic patients with B-acute lymphoblastic leukemia;Cruz-Rodriguez;J Exp Clin Cancer Res.,2016

5. Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden;Katz;Cancer Causes Control.,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal Models of Lymphoid Malignancies;Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies;2023-03-15

2. Modeling leukemia with zebrafish (Danio rerio): Towards precision medicine;Experimental Cell Research;2022-12

3. Patient-Derived Xenotransplant of CNS Neoplasms in Zebrafish: A Systematic Review;Cells;2022-04-02

4. Noncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation;Nature Genetics;2022-02

5. Altered plasma, urine, and tissue profiles of sulfatides and sphingomyelins in patients with renal cell carcinoma;2022-01-10